alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
§ 4.104 How and where must you submit postmarketing safety reports for your combination product or constituent part? ( a ) If you are a constituent part applicant, you must submit postmarketing safety reports in accordance with the regulations identified in § 4.102(b) that are applicable to your product based on its application type.
( b ) If you are a combination product applicant, you must submit postmarketing safety reports required under § 4.102 in the manner specified in the regulation applicable to the type of report, with the following exceptions: ( 1 ) You must submit the postmarketing safety reports identified in § 4.102(c)(1)(i) and (ii) in accordance with § 314.80(g) of this chapter if your combination product received marketing authorization under an NDA or ANDA or in accordance with § 600.80(h) of this chapter if your combination product received marketing authorization under a BLA.
( 2 ) You must submit the postmarketing safety reports identified in § 4.102(c)(2)(ii) and (c)(3)(ii) in accordance with § 803.12(a) of this chapter if your combination product received marketing authorization under a device application.
§ 1306.21 Requirement of prescription. ( a ) A pharmacist may dispense directly a controlled substance listed in Schedule III, IV, or V that is a prescription drug as determined under section 503(b) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 353(b)) only pursuant to either a paper prescription signed by a practitioner, a facsimile of a signed paper prescription transmitted by the practitioner or the practitioner's agent to the pharmacy, an electronic prescription that meets the requirements of this part and part 1311 of this chapter, or an oral prescription made by an individual practitioner and promptly reduced to writing by the pharmacist containing all information required in § 1306.05, except for the signature of the practitioner.
( b ) An individual practitioner may administer or dispense directly a controlled substance listed in Schedule III, IV, or V in the course of his/her professional practice without a prescription, subject to § 1306.07.
( c ) An institutional practitioner may administer or dispense directly (but not prescribe) a controlled substance listed in Schedule III, IV, or V only pursuant to a paper prescription signed by an individual practitioner, a facsimile of a paper prescription or order for medication transmitted by the practitioner or the practitioner's agent to the institutional practitioner-pharmacist, an electronic prescription that meets the requirements of this part and part 1311 of this chapter, or an oral prescription made by an individual practitioner and promptly reduced to writing by the pharmacist (containing all information required in § 1306.05 except for the signature of the individual practitioner), or pursuant to an order for medication made by an individual practitioner that is dispensed for immediate administration to the ultimate user, subject to § 1306.07.
[62 FR 13965, Mar. 24, 1997, as amended at 75 FR 16308, Mar. 31, 2010]
I 

118TH CONGRESS 

2D SESSION H. R. 7374 

To designate the facility of the United States Postal Service located at 

500 Sergeant Gonzales Drive in Fort Davis, Texas, as the ‘‘Sergeant 

Manuel Sillas Gonzales Post Office’’. 

IN THE HOUSE OF REPRESENTATIVES 

FEBRUARY 15, 2024 

Mr. TONY GONZALES of Texas (for himself, Mr. FALLON, Mr. VICENTE GONZALEZ of Texas, Mr. CLOUD, Mrs. FLETCHER, and Mr. VEASEY) introduced the following bill; which was referred to the Committee on Oversight and Accountability 

A BILL 

To designate the facility of the United States Postal Service 

located at 500 Sergeant Gonzales Drive in Fort Davis, 

Texas, as the ‘‘Sergeant Manuel Sillas Gonzales Post 

Office’’. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SERGEANT MANUEL SILLAS GONZALES POST 

4 OFFICE. 

5 (a) DESIGNATION.—The facility of the United States 

6 Postal Service located at 500 Sergeant Gonzales Drive in 


kjohnson on DSK7ZCZBW3PROD with $$_JOB
2 

•HR 7374 IH

1 Fort Davis, Texas, shall be known and designated as the 

2 ‘‘Sergeant Manuel Sillas Gonzales Post Office’’. 

3 (b) REFERENCES.—Any reference in a law, map, reg4 ulation, document, paper, or other record of the United 

5 States to the facility referred to in subsection (a) shall 

6 be deemed to be a reference to the ‘‘Sergeant Manuel 

7 Sillas Gonzales Post Office’’. 

Æ 


kjohnson on DSK7ZCZBW3PROD with $$_JOB
# LI2019179EN.01000101.xml

| 3.7.2019 | EN | Official Journal of the European Union | LI 179/1 |
| --- | --- | --- | --- |

3.7.2019

EN

Official Journal of the European Union

LI 179/1

---

EUROPEAN COUNCIL DECISION (EU) 2019/1135

of 2 July 2019

electing the President of the European Council

THE EUROPEAN COUNCIL,

Having regard to the Treaty on European Union, and in particular Article 15(5) thereof,

Whereas:

| (1) | On 30 November 2019, the term of office of the current President of the European Council, Mr Donald TUSK, will come to an end. |
| --- | --- |

(1)

On 30 November 2019, the term of office of the current President of the European Council, Mr Donald TUSK, will come to an end.

| (2) | A new President of the European Council should therefore be elected, |
| --- | --- |

(2)

A new President of the European Council should therefore be elected,

HAS ADOPTED THIS DECISION:

Article 1

Mr Charles MICHEL is hereby elected President of the European Council for the period from 1 December 2019 until 31 May 2022.

Article 2

This Decision shall be notified to Mr Charles MICHEL by the Secretary-General of the Council.

Article 3

This Decision shall be published in the Official Journal of the European Union.

Done at Brussels, 2 July 2019.

For the European Council

The President

D. TUSK

---
Editorial Note on Part 316
Editorial Note: Nomenclature changes to part 316 appear at 69 FR 13717, Mar. 24, 2004.

§ 316.28 Publication of orphan-drug designations. Each month FDA will update a publicly available cumulative posting of all drugs designated as orphan drugs. These postings will contain the following information: ( a ) The name and address of the sponsor;
( b ) The generic name and trade name, if any, or, if neither is available, the chemical name or a meaningful descriptive name of the drug;
( c ) The date of the granting of orphan-drug designation;
( d ) The designated use in the rare disease or condition; and
( e ) If the drug loses designation after August 12, 2013, the date of it no longer having designation.
[78 FR 35134, June 12, 2013]
```

[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H.R. 7100 Reported in House (RH)]

<DOC>

                                                 Union Calendar No. 545
118th CONGRESS
  2d Session
                                H. R. 7100

                          [Report No. 118-648]

 To amend title 38, United States Code, to clarify the organization of 
   the Office of Survivors Assistance of the Department of Veterans 
                                Affairs.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                            January 29, 2024

Mr. Ciscomani (for himself and Mr. Bost) introduced the following bill; 
        which was referred to the Committee on Veterans' Affairs

                           September 6, 2024

   Committed to the Committee of the Whole House on the State of the 
                    Union and ordered to be printed

_______________________________________________________________________

                                 A BILL

 
 To amend title 38, United States Code, to clarify the organization of 
   the Office of Survivors Assistance of the Department of Veterans 
                                Affairs.

 

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Prioritizing Veterans' Survivors 
Act''.

SEC. 2. CLARIFICATION OF ORGANIZATION OF THE OFFICE OF SURVIVORS 
              ASSISTANCE OF THE DEPARTMENT OF VETERANS AFFAIRS.

    Section 321(a) of title 38, United States Code, is amended by 
striking ``in the Department'' and inserting ``in the Office of the 
Secretary''.
                                                 Union Calendar No. 545

118th CONGRESS

  2d Session

                               H. R. 7100

                          [Report No. 118-648]

_______________________________________________________________________

                                 A BILL

 To amend title 38, United States Code, to clarify the organization of 
   the Office of Survivors Assistance of the Department of Veterans 
                                Affairs.

_______________________________________________________________________

                           September 6, 2024

Committed to the Committee of the Whole House on the State of the Union 
                       and ordered to be printed
```
Exhibit 4.1


 


THE BANK OF NEW YORK MELLON


NEW YORK’S FIRST BANK-FOUNDED 1784 BY ALEXANDER HAMILTON


 


 


2 HANSON PLACE, 12TH FLOOR, BROOKLYN,
N.Y. 11217


 


 


 


May 2, 2017


 


Hennion & Walsh, Inc.


2001 Route 46, Waterview Plaza


Parsippany, New Jersey 07054


 


Smart Trust 316


 


Dear Sirs:


The Bank of New York
Mellon is acting as trustee for the series of Smart Trust set forth above (the “Trust”). We enclosed a list
of the Securities to be deposited in the Trust on the date hereof. The prices indicated therein reflect
our evaluation of such Securities as of close of business on May 1, 2017, in accordance with the valuation method set forth in
the Standard Terms and Conditions of Trust and Trust Agreement. We consent to the reference to The Bank of New York Mellon as the
party performing the evaluations of the Trust Securities in the Registration Statement (No. 333-216424) filed with the Securities
and Exchange Commission with respect to the registration of the sale of the Trust Units and to the filing of this consent as an
exhibit thereto.


 


 


Very truly yours,


 


/s/ GERARDO CIPRIANO________________


Gerardo Cipriano


Vice President
<PAGE>

                                                                    EXHIBIT 21.1

                             LEVEL 8 SYSTEMS, INC.
             LIST OF SUBSIDIARIES BY JURISDICTION OF INCORPORATION


All Companies are 100% owned unless otherwise noted.


Australia: (Both Offices are in the process of being closed.)

  Level 8 Systems Australia Pty Limited

  Template Software SE Asia Pty


Austria: (This office is in the process of being closed.)

  Milestone Software GmbH

Barbados:

  Level 8 FSC, Inc.

Benelux:

  Level 8 Benelux B.V.

Canada:

  Level 8 Canada, Inc.
    Domestic Province:           Ontario

    3020126 Canada Inc.
    Domestic Province:           Canada

Denmark:

  Level 8 Denmark ApS

France:

  Level 8 France S.A.R.L.

  Template Software S.A.

Germany:

  Level 8 Europe (Deutschland) GmbH

  Template Software GmbH

  Template Software Holding GmbH

  Template Software Geschaftsfuhrungs GmbH
<PAGE>

Ireland:

  Level 8 Ireland Limited

Italy:

  Level 8 Italia S.r.L.

Mexico:

  SEER Technologies de Mexico S.A. de C.V. (Closed)

  Template Software de Mexico, S.A. de C.V. (This office is in the process of
being closed.)

Korea: (This office is in the process of being closed.)

  SEER Korea Co., Limited

Spain: (This office is in the process of being closed.)

  Level 8 Espana, S.L.

Sweden:

  Level 8 Systems Nordic AB

Switzerland:

  Milestone Software AG (20% owned)

United Kingdom:

  Level 8 Systems (U.K.) Limited

  Template Software, UK Limited

  Template Software Limited

United States:

Parent Company:

  Level 8 Systems, Inc.
    State of Incorporation:      Delaware

Subsidiary:

  SEER Technologies, Inc.
    State of Incorporation:      Delaware

  Level 8 Technologies, Inc.
    State of Incorporation:      New York
<PAGE>

  SEER Technologies (Worldwide Holdings) Limited
    State of Incorporation:      Delaware

  ProfitKey International, Inc.
    State of Incorporation:      Delaware

  StarQuest Software, Inc.
    State of Incorporation:      California

  Level 8 Worldwide Holdings Limited
    State of Incorporation:      Delaware
Fourth Court of Appeals

San Antonio, Texas

October 3, 2018

No. 04-18-00646-CV

IN THE INTEREST OF J.A.R. JR., J.R.R. AND A.I.T.,

From the 131st Judicial District Court, Bexar County, Texas

Trial Court No. 2017-PA-02660

Honorable Charles E. Montemayor, Judge Presiding

ORDER

This is an accelerated appeal of an order terminating the appellant’s parental rights,

which must be disposed of by this court within 180 days of the date the notice of appeal is filed. 

TEX. R. JUD. ADMIN. 6.2. The reporter’s record was originally due on September 20, 2018. On 

September 26, 2018, the court reporter filed a notification of late record requesting an extension 

of time to file the reporter’s record until October 12, 2018. It is therefore ORDERED that the 

reporter’s record must be filed in this appeal no later than October 12, 2018. TEX. R. APP. P.

35.3(c). FURTHER REQUESTS FOR EXTENSIONS OF TIME ARE DISFAVORED.

_________________________________

Sandee Bryan Marion, Chief Justice

IN WITNESS WHEREOF, I have hereunto set my hand and affixed the seal of the said 

court on this 3rd day of October, 2018.

___________________________________

KEITH E. HOTTLE,

Clerk of Court
John R. Kasich, Governor MaryTaylor, Lt. Governor CraigW. Butler, Director 

## SEP 5 2014 Susan Hedman Regional Administrator USEPA Region 5 77 WestJackson Boulevard 

### Mail Code: R-19J Chicago, IL 60604-3507 

### RE: Withdrawal ofRequestforSIP Approval ofparagraph (B)(1)(b) ofOAC Rule 3745- 17-03 

### Regardingan Alternative Procedurefor Determining Compliancewith Ohio's Opacitylimitation.
Dear Ms. Hedman, On June 4, 2003, Ohio submitted a State Implementation Plan (SIP) request regarding incorporation of changes to Ohio Administrative Code (OAC) Chapter 17 for the regulation of particulate matter. On June 27, 2005, U.S. EPA proposed disapproval of a portion of OAC Rule 3745-17-03; specifically regarding provisions for the use of continuous opacity monitoring (COMs) measurements to determine compliance with Ohio's 20% opacity limitation (currently contained within paragraph (B)(1)(b)). Years passed without anyfurther action on the 2005 proposed disapproval. Then on June 26, 2014, U.S. EPA noticed a supplemental proposal specifically requesting comments on whether any events have occurred or any policy considerations have occurred, since the 2005 proposed disapproval that should be considered as U.S. EPAtakesfinal action on the 2005 proposed disapproval.
At this time, Ohio EPA would like to request withdrawal of our June 4, 2003 request to incorporate paragraph (B)(1)(b) into Ohio's SIP. Substantial time has passed since our June 4, 2003 submittal and circumstances have changed. This SIP revision request is no longer necessary at this time. Ohio EPAwill be pursuing more relevant rule changes based on current circumstancesforfacilitieswithin the State. Sincerely, 

# r**~iS.'=-- ~~Butler** 

Director, Ohio EPA
Cc: Bob Hodanbosi, Chief, Division ofAir Pollution Control, Ohio EPA DouglasAburano, Chief, Attainment Planning and Maintenance Section, U.S.EPA

50WestTown Street,_ Suite 700 (/J P.O. Box 1049 "'Columbus, OH 43216-1.049 www.epa.ohio.gov • (614) 644-3020 • (614) 644-3184 (fax)
<PAGE>

                  CONSENT OF INDEPENDENT PUBLIC ACCOUNTANTS

As independent public accountants, we hereby consent to the incorporation of 
our report included in this Amended Annual Report on Form 10-K/A, into NHP's 
Registration Statement on Form S-8 (No. 333-11933), NHP's Registration 
Statement on Form S-8 (No. 333-11863), NHP's Registration Statement on Form 
S-8 (No. 333-11917), NHP's Registration Statement on Form S-8 (No. 
333-11857), and NHP's Registration Statement on Form S-8 (No. 333-08137), all 
previously filed.

                                           /s/ Arthur Andersen LLP

   
Washington, D.C.
October 27, 1997
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of the Treasury

###### Office of Thrift Supervision

          - [AC-35: OTS No. H-4649]

                    Notice is hereby given that on February 12, 2010, the Office of Thrift Supervision approved the application of Harvard Savings Bank, Harvard, Illinois, to convert to the stock form of organization. Copies of the application are available for inspection by appointment (phone number: 202-906-5922 or e-mail                     *Public.Info@OTS.Treaas.gov*) at the Public Reading Room, 1700 G Street, NW., Washington, DC 20552, and the OTS Central Regional Office, 1 South Wacker Drive, Suite 2000, Chicago, Illinois 60606.                

Dated: February 19, 2010.

By the Office of Thrift Supervision.

Sandra E. Evans,

Federal Register Liaison.

[FR Doc. 2010-3897 Filed 2-26-10; 8:45 am]

BILLING CODE 6720-01-M
April 24, 2009

Tony Britten, Team Leader Emergency Response Team U.S. EPA Office of Pesticide Programs (7505P) Document Processing Desk (EMEX) One Potomac Yard, Room S4900 2777 Crystal Drive Arlington, VA 22202

Dear Mr. Britten,

Wisconsin Department of Agriculture, Trade & Consumer Pr otection (WDATCP) requests a specific emergency exemption under the provisions of Section 18 of the Federal Insecticid e, Fungicide and Rodenticide Act, as amended, for use of spirotetramat formulated as the product MoventoTM (EPA Reg. No. 264-1050) on dry bulb onions to control onion thrips, and incorporates by reference any supplemental supporting information in a similar request submitted by the Colorado Department of Agriculture. This is the first year that WDATCP has requested this use.

Please note Dr. Russell Groves’ discussion on page 5 regarding the need to have a sufficient number of effective products

with different modes of action.

Based on the Section 3 product label, the active ingredient has environmental properties (mobility and runoff potential) and ecotoxicity (acute toxicity to aquatic invertebrates) that may be of concern for groundwat er and/or surface water. However, Dr. Russell Groves of University of Wisconsin-Madison reports that almost the entire dry bulb onion crop in Wisconsin is grown on muck soils and that very few operators, which are small, grow onions for fresh market product on mineral soils. We note general concerns about potential impacts on endangered species based on the product’s toxicity to aquatic invertebrates, either directly (mussels) or indirectly (birds that depend on aquatic invertebrates as a food source); however, these species are in discrete locations, a maximum of 10 oz product/acre would be applied, and the environmental hazards

section of the Section 3 label does outlin e precautions designed to prevent drift and runoff and to protect aquatic organisms. The active ingredient has ecotoxicity (toxicity to honey bee larv ae) that may be of concern fo r bees. However, Dr. Groves reports that onions don’t set seed in Wisconsin -- Wisconsin growers typically influence the crop to grow vegetatively to ensure energy goes into bulbing rather than seed. In the absence of blooms we would not expect adult honey bees to visit onion plants and, therefore, would not expect exposure via pollen/nectar to pose an issue for honey bee larvae.

If you have any questions regarding this application, please let me know.

Sincerely,

Matt Sunseri Pesticide/IPM Program Specialist Wisconsin Department of Agriculture, Trade and Consumer Protection 2811 Agriculture Drive

PO Box 8911 Madison, WI 53708-8911 (608) 224-4547 matthew.sunseri@wisconsin.gov
# ART Success Rates

Print

Minus

NASS
Learn more about CDC’s National ART Surveillance System.

IVF Success Estimator
Estimate your chance of having a live birth using in vitro fertilization (IVF).

Fertility clinics in the U.S. report and verify data on the assisted reproductive technology (ART) cycles started and carried out in their clinics, and the outcomes of these cycles, during each calendar year.  ART includes all fertility treatments in which either eggs or embryos are handled.  The main type of ART is in vitro fertilization (IVF). IVF involves extracting a woman’s eggs, fertilizing the eggs in the laboratory, and then transferring the resulting embryos into the woman’s uterus through the cervix.

These ART data are a rich source of information that can give potential ART users an idea of their average chances of success per ART cycle or ART transfer.  Average chances, however, do not necessarily apply to an individual or couple.  ART success rates vary in the context of patient and treatment characteristics, such as age, infertility diagnosis, number of embryos transferred, type of ART procedure, use of techniques such as ICSI, and history of previous births, miscarriages, and ART cycles. People considering ART should consult a physician to discuss their treatment options.

Based on CDC’s 2021 Fertility Clinic Success Rates Report, approximately 238,126 patients had 413,776 ART cycles performed at 453 reporting clinics in the United States during 2021, resulting in 91,906 live births (deliveries of one or more living infants) and 97,128 live born infants. Of the 413,776 ART cycles performed in 2021, 167,689 were egg or embryo banking cycles in which all resulting eggs or embryos were frozen for future use. Although the use of ART is still relatively rare as compared to the potential demand, its use has more than doubled over the past decade. Approximately 2.3% of all infants born in the United States every year are conceived using ART.

## 2021 ART Success Rates

**Zip Code****Distance**5 Miles10 Miles20 Miles50 Miles100 Miles

2021 pooled data from all reporting clinics in the US

National ART Success Rates

State Specific ART Surveillance

How to Access and Interpret Fertility Clinic Success Rates

ART Fertility Clinic and National Summary Report

ART Fertility Clinic Success Rates Dataset

Archived ART Reports and Spreadsheets

Glossary of Terms

                          - HHS Office on Women’s Health
                          - Resolve
                          - Path 2 Parenthood

                          - Society for Assisted Reproductive Technology (SART)
                          - American Society for Reproductive Medicine (ASRM)
                          - 

Top of Page

January 8, 2024
National Center for Chronic Disease Prevention and Health PromotionDivision of Reproductive Health

- Facebook
- Twitter
- LinkedIn
- Syndicate